BANGERLABS
Fulfilled in the USA Batch Produced & Tested Fast & Discreet Shipping ≥99% Purity Guaranteed COA Every Batch Independently Tested 24/7 Support Fulfilled in the USA Batch Produced & Tested Fast & Discreet Shipping ≥99% Purity Guaranteed COA Every Batch Independently Tested 24/7 Support

HGH Fragment 176-191: Research Overview — Mechanism, Research Areas & References

By the Banger Labs Research Team · Updated June 2026

HGH Fragment 176-191 research peptide

Short answer: HGH Fragment 176-191 is a synthetic 16-amino-acid peptide corresponding to the C-terminal region (residues 176-191) of human growth hormone, studied in preclinical research models in the context of lipid metabolism. This material is intended for research use only and is not a drug or therapeutic product.

What is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic peptide that reproduces the C-terminal amino acid sequence (residues 176-191) of the human growth hormone (hGH) polypeptide. It belongs to the class of growth-hormone-derived fragment peptides; a closely related Tyr-modified analog of this region has been described in the literature as AOD9604. As a fragment, it lacks the full hGH structure and the regions associated with growth-hormone-receptor binding.

HGH Fragment 176-191 — molecular structure (research illustration)

How HGH Fragment 176-191 is studied

In preclinical models, C-terminal hGH fragments of this region have been investigated for effects on adipose-tissue lipid metabolism, including reported antilipogenic activity (reduced de novo fat synthesis) and modulation of lipolytic pathways. Rodent studies of the related fragment reported changes correlating with beta-3 adrenergic receptor (β3-AR) RNA expression, and effects differed in β3-AR knockout models, implicating that pathway. Reported research observations indicate these fragments act on lipid metabolism in models without the IGF-1 elevation characteristic of full-length growth hormone, consistent with not engaging the growth-hormone receptor in the same manner.

HGH Fragment 176-191 — receptor & cell-signaling research illustration

Research areas

  • Studied in in vitro adipocyte and adipose-tissue models examining lipid metabolism
  • Investigated in rodent models for its relationship to beta-3 adrenergic receptor (β3-AR) expression and lipid pathways
  • Examined in preclinical work on inhibition of de novo lipogenesis (antilipogenic activity)
  • Used as a structure-activity research tool to localize the lipid-metabolism-active domain within the hGH C-terminus
  • Studied as a research model for separating lipid-metabolism-related activity from the IGF-1 response associated with full-length growth hormone

These describe laboratory/preclinical research only. No therapeutic, medical, or efficacy claims are made.

HGH Fragment 176-191 research in a laboratory setting

HGH Fragment 176-191 specifications

Class Synthetic C-terminal peptide fragment of human growth hormone (16-amino-acid hGH 176-191 sequence)
Form Lyophilized powder (reconstitute with bacteriostatic water)
Purity standard ≥ 99% HPLC
Certificate of Analysis Available per batch on request
Use Research use only — not for human or veterinary use

Handling & quality

HGH Fragment 176-191 is held to a ≥ 99% HPLC purity standard with a Certificate of Analysis available per batch. Reconstitute with bacteriostatic water and store refrigerated; handle strictly for research. See reconstitution & storage.

HGH Fragment 176-191 vial — research-grade detail

Frequently asked questions

What is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic peptide that reproduces the C-terminal amino acid sequence (residues 176-191) of the human growth hormone (hGH) polypeptide. It belongs to the class of growth-hormone-derived fragment peptides; a closely related Tyr-modified analog of this region has been described in the literature as AOD9604. As a fragment, it lacks the full hGH structure and the regions associated with growth-hormone-receptor binding.

Is HGH Fragment 176-191 research use only?

Yes. HGH Fragment 176-191 is supplied strictly for laboratory research — not for human or veterinary use, and not as a drug, food, or supplement.

Does Banger Labs provide a COA for HGH Fragment 176-191?

Yes — a Certificate of Analysis (HPLC purity + mass-spec identity) is available per batch on request. See the COA Library.

References

  1. Wu Z, Ng FM. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. Biochem Mol Biol Int. 1993;30(1):187-96.PubMed (NCBI)
  2. AOD9604 (Tyr-modified hGH 176-191 fragment) — overview of structure and classWikipedia (reference overview)

Sources are provided for scientific reference and describe laboratory/preclinical research; they do not constitute medical advice or efficacy claims.

Shop HGH Fragment 176-191 & related research peptides

Shop HGH Fragment 176-191 →

By the Banger Labs Research Team. For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. Educational information, not medical advice.